Literature DB >> 26942609

Sympathetic Nervous System, Hypertension, Obesity and Metabolic Syndrome.

Gino Seravalle1, Guido Grassi2,3.   

Abstract

Experimental and clinical studies have clearly shown the role of the sympathetic nervous system in the pathophysiology of several cardiovascular and non-cardiovascular diseases. This short review will be aimed at focusing and discussing the new information collected on two specific clinical conditions such as obesity and metabolic syndrome. The paper will briefly describe the four main mechanisms that represent the common link between these two pathophysiological conditions and that through the sympathetic nervous system contribute to increase the cardiovascular risk.

Entities:  

Keywords:  Baroreflex; Insulin resistance; Leptin; Metabolic syndrome; Obesity; Sympathetic nervous system

Mesh：

Substances：

Year:  2016        PMID： 26942609     DOI： 10.1007/s40292-016-0137-4

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN： 1120-9879


  44 in total

Review 1.  The link between abdominal obesity, metabolic syndrome and cardiovascular disease.

Authors:  S A Ritchie; J M C Connell
Journal:  Nutr Metab Cardiovasc Dis       Date:  2006-11-15       Impact factor: 4.222

2.  Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives.

Authors:  Guido Grassi; Raffaella Dell'Oro; Annalisa Facchini; Fosca Quarti Trevano; Giovanni Battista Bolla; Giuseppe Mancia
Journal:  J Hypertens       Date:  2004-12       Impact factor: 4.844

3.  Comparison of gene transcription between subcutaneous and visceral adipose tissue in Chinese adults.

Authors:  Juan Min Zha; Wen Juan Di; Ting Zhu; Yu Xie; Jing Yu; Juan Liu; Peng Chen; Guoxian Ding
Journal:  Endocr J       Date:  2009-06-30       Impact factor: 2.349

4.  Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity.

Authors:  Guido Grassi; Anna Facchini; Fosca Quarti Trevano; Raffaella Dell'Oro; Francesca Arenare; Francesco Tana; GianBattista Bolla; Anna Monzani; Maria Robuschi; Giuseppe Mancia
Journal:  Hypertension       Date:  2005-06-27       Impact factor: 10.190

5.  The effect of metformin and insulin on sympathetic nerve activity, norepinephrine spillover and blood pressure in obese, insulin resistant, normoglycemic, hypertensive men.

Authors:  S Gudbjörnsdottir; P Friberg; M Elam; S Attvall; P Lönnroth; B G Wallin
Journal:  Blood Press       Date:  1994-11       Impact factor: 2.835

6.  Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea.

Authors:  Elise Belaidi; Marie Joyeux-Faure; Christophe Ribuot; Sandrine H Launois; Patrick Levy; Diane Godin-Ribuot
Journal:  J Am Coll Cardiol       Date:  2009-04-14       Impact factor: 24.094

7.  Obesity in adulthood and its consequences for life expectancy: a life-table analysis.

Authors:  Anna Peeters; Jan J Barendregt; Frans Willekens; Johan P Mackenbach; Abdullah Al Mamun; Luc Bonneux
Journal:  Ann Intern Med       Date:  2003-01-07       Impact factor: 25.391

8.  Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation.

Authors:  Markus P Schlaich; Elisabeth Lambert; David M Kaye; Zygmunt Krozowski; Duncan J Campbell; Gavin Lambert; Jacqui Hastings; Anuradha Aggarwal; Murray D Esler
Journal:  Hypertension       Date:  2003-11-10       Impact factor: 10.190

9.  Subcutaneous obesity is not associated with sympathetic neural activation.

Authors:  Guy E Alvarez; Tasha P Ballard; Stacy D Beske; Kevin P Davy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-02-26       Impact factor: 4.733

10.  Sympathetic regulation of vascular function in health and disease.

Authors:  Rosa M Bruno; Lorenzo Ghiadoni; Gino Seravalle; Raffaella Dell'oro; Stefano Taddei; Guido Grassi
Journal:  Front Physiol       Date:  2012-07-24       Impact factor: 4.566
View more
  33 in total

Review 1.  Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management.

Authors:  Yingmei Zhang; Adam T Whaley-Connell; James R Sowers; Jun Ren
Journal:  Pharmacol Ther       Date:  2018-06-22       Impact factor: 12.310

Review 2.  Sensory signals mediating high blood pressure via sympathetic activation: role of adipose afferent reflex.

Authors:  Carolina Dalmasso; Jacqueline R Leachman; Jeffrey L Osborn; Analia S Loria
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-12-23       Impact factor: 3.619

Review 3.  Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension.

Authors:  Thierry H Le Jemtel; William Richardson; Rohan Samson; Abhishek Jaiswal; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2017-02       Impact factor: 5.369

Review 4.  Path of translational discovery of urological complications of obesity and diabetes.

Authors:  Firouz Daneshgari; Guiming Liu; Ann T Hanna-Mitchell
Journal:  Am J Physiol Renal Physiol       Date:  2017-01-04

5.  Soluble Prorenin Receptor Increases Blood Pressure in High Fat-Fed Male Mice.

Authors:  Eva Gatineau; Ming C Gong; Frédérique Yiannikouris
Journal:  Hypertension       Date:  2019-08-05       Impact factor: 10.190

Review 6.  Obesity-Induced Hypertension: Brain Signaling Pathways.

Authors:  Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Taolin Fang; Nicola Aberdein; Cecilia E P de Lara Rodriguez; John E Hall
Journal:  Curr Hypertens Rep       Date:  2016-07       Impact factor: 5.369

7.  Hypertension, C Reactive Protein and Metabolic Profile: What is the Scenario in Patients Undergoing Arteriography?

Authors:  Ricardo Jose Tofano; Sandra Maria Barbalho; Marcelo Dib Bechara; Karina Quesada; Claudemir Gregorio Mendes; Marie Oshiiwa
Journal:  J Clin Diagn Res       Date:  2017-08-01

Review 8.  Renal denervation: dark past, bright future?

Authors:  Marshall Heradien; Felix Mahfoud; Doug Hettrick; Paul Brink
Journal:  Cardiovasc J Afr       Date:  2019 Sep/Oct       Impact factor: 1.167

Review 9.  Improving obesity and blood pressure.

Authors:  Masami Tanaka
Journal:  Hypertens Res       Date:  2019-10-25       Impact factor: 3.872

10.  Relationship between obesity and blood pressure among employees in the Vhembe district municipality of Limpopo Province, South Africa.

Authors:  Takalani Clearance Muluvhu; Makama Andries Monyeki; Gert Lukas Strydom; Abel Lamina Toriola
Journal:  Cardiovasc J Afr       Date:  2019-09-12       Impact factor: 1.167
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.